Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ADRX

Updated 10/6/2026, 8:56 AM ET.

ADRX

ADARx Pharmaceuticals, Inc.

Buy$1,045,772

Chimovits Erez

Director

61,516 shat $17.00Filed Sep 30, 5:29 PM ETFiling
ADRX

ADARx Pharmaceuticals, Inc.

Buy$16,150,000

GORDON CARL L

Director, 10% owner

950,000 shat $17.00Filed Sep 30, 5:25 PM ETFiling
ADRX

ADARx Pharmaceuticals, Inc.

Buy$16,150,000

ORBIMED ADVISORS LLC

Director, 10% owner

and 4 others

950,000 shat $17.00Filed Sep 30, 5:23 PM ETFiling
ADRX

ADARx Pharmaceuticals, Inc.

Buy$27,200,000

SR ONE CAPITAL MANAGEMENT, LLC

10% owner

1,600,000 shat $17.00Filed Sep 29, 9:45 PM ETFiling
ADRX

ADARx Pharmaceuticals, Inc.

Buy$27,200,000

George Simeon

Director, 10% owner

1,600,000 shat $17.00Filed Sep 29, 9:43 PM ETFiling

Read from public SEC filings. Not financial advice.